Merck & Co Inc (NYSE: MRK) Q4 2020 earnings call dated Feb. 04, 2021
Corporate Participants:
Peter Dannenbaum — Vice President, Investor Relations
Kenneth C. Frazier — Chairman of the Board and Chief Executive Officer
Robert M. Davis — Executive Vice President, Global Services, and Chief Financial Officer
Dean Y. Li — Executive Vice President and President, Merck Research Laboratories
Michael T. Nally — Executive Vice President and Chief Marketing Officer
Analysts:
Seamus Fernandez — Guggenheim Partners — Analyst
Andrew Baum — Citi — Analyst
Terence Flynn — Goldman Sachs — Analyst
Chris Schott — JPMorgan — Analyst
Louise Chen — Cantor — Analyst
David Risinger — Morgan Stanley — Analyst
Daina Graybosch — SVB Leerink — Analyst
Umer Raffat — Evercore ISI — Analyst
Steve Scala — Cowen — Analyst
Navin Jacob — UBS — Analyst
Gregg Gilbert — Truist — Analyst
Mara Goldstein — Mizuho — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
Listen On
